4//SEC Filing
KISNER DANIEL L 4
Accession 0001062993-22-015042
CIK 0001621443other
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 9:53 PM ET
Size
8.7 KB
Accession
0001062993-22-015042
Insider Transaction Report
Form 4
KISNER DANIEL L
Director
Transactions
- Award
Common Stock
2022-06-14+23,109→ 28,109 total - Sale
Common Stock
2022-06-14$1.01/sh−40$40→ 28,069 total - Award
Stock Option (right to buy)
2022-06-14+34,663→ 34,663 totalExercise: $1.01Exp: 2032-06-14→ Common Stock (34,663 underlying)
Footnotes (3)
- [F1]The restricted stock award vests in full upon the earlier of (i) June 14, 2023 or (ii) the day before the Company's 2023 annual meeting of stockholders.
- [F2]This transaction represents shares required to be sold by the Reporting Person to satisfy certain equity plan administrator fees in connection with the vesting of shares of restricted stock. This sale was mandated by the equity plan administrator and does not represent a discretionary trade by the Reporting Person.
- [F3]The option vests in full upon the earlier of (i) June 14, 2023 or (ii) the day before the Company's 2023 annual meeting of stockholders.
Issuer
Zynerba Pharmaceuticals, Inc.
CIK 0001621443
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001073407
Filing Metadata
- Form type
- 4
- Filed
- Jun 15, 8:00 PM ET
- Accepted
- Jun 16, 9:53 PM ET
- Size
- 8.7 KB